Edition:
United States

Profile: Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

513.85INR
22 Sep 2017
Change (% chg)

Rs-5.80 (-1.12%)
Prev Close
Rs519.65
Open
Rs518.95
Day's High
Rs528.50
Day's Low
Rs508.70
Volume
7,990,848
Avg. Vol
5,647,133
52-wk High
Rs790.75
52-wk Low
Rs432.70

Sun Pharmaceutical Industries Limited is a pharmaceuticals company. The Company's business segments include US Business, Indian Branded Generics Business, Emerging Markets, Global Consumer Healthcare Business and Active Pharmaceutical Ingredients (API). Its Rest of World segment includes Western Europe, Canada, Australia, New Zealand and other markets. The Company offers its products to therapy areas, such as cardiology, neuro-psychiatry, gastroenterology, anti-infective, diabetology and dermatology. The Company's products include AB PHYLLINE, ABZORB DUSTING POWDER, ACAMPROL, ACOSTIN 3 MIU, ACOSTIN FORTE and AB PHYLLINE SR 200. Its manufacturing units are situated in India, the United States and Brazil, among others. Its units produce generics, branded generics, specialty products, over-the-counter (OTC) products, anti-retroviral (ARVs) and APIs. They also produce intermediates in a range of dosage forms, including tablets, capsules, injectables, ointments, creams and liquids.

Company Address

Sun Pharmaceutical Industries Ltd

Acme Plaza
Andheri Kurla Road, Andheri East
MUMBAI     400063
P: +9122.43244324
F: +91265.2354897

Company Web Links